AstraZeneca rejects latest Pfizer approach

Monday, 19 May 2014, 4:33 pm

Wow - AstraZeneca has rejected Pfizer's fresh £55.00 a share offer.

Now, I have to admit I didn't see that coming. I thought the raise would allow both companies to at least start talking and get an extension to the "put up or shut up" deadline.

Indeed, one of my good sources on this story always thought this deal would deal would happen despite the public rejections from AstraZeneca and browbeating from British politicians.

So, one of more final twist in the tale? Who knows...  ..



[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Post Comment